Amlodipine And Olmesartan Medoxomil Tablet
Product Images NDC 42571-238

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 42571-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipineolmesartan Lbl A

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/20 mg, oral tablets supplied in a bottle of 30 tablets. Manufactured by Micro Labs Limited, India, and for Micro Labs USA Inc., Somerset, NJ. The label includes dosage instructions to see the package insert and storage conditions at 25°C with permitted excursions from 15° to 30°C.*

FDA Label Image

Amlodipineolmesartan Lbl B

Label for Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg, manufactured by Micro Labs Limited and for Micro Labs USA Inc. The label indicates 30 tablets per package and includes storage instructions, barcode, and regulatory information including NDC 42571-236-30.*

FDA Label Image

Amlodipineolmesartan Lbl C

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/40 mg, oral tablets, containing 5 mg amlodipine and 40 mg olmesartan medoxomil per tablet. The label states Rx only and includes a 30-tablet count. Manufactured by Micro Labs Limited in Goa, India, and manufactured for Micro Labs USA Inc., Somerset, NJ. Storage instructions specify 25°C with allowable excursions. The NDC number is 42571-237-30.*

FDA Label Image

Amlodipineolmesartan Lbl D

Label for Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/40 mg strength, in a package of 30 tablets. The label shows the NDC 42571-238-30, manufactured by Micro Labs Limited in India and for Micro Labs USA Inc. It includes storage instructions and a barcode.*

FDA Label Image

Figure 2 (Amlodipineolmesartanf2)

A line graph showing the probability of achieving diastolic blood pressure (DBP) less than 90 mmHg at Week 8 with LOCF. The graph compares placebo, Amlodipine 10 mg, Olmesartan medoxomil 40 mg, and the combination of Amlodipine and Olmesartan medoxomil 10/40 mg across baseline DBP values from 95 to 110 mmHg.*

FDA Label Image

Fig 3 (Amlodipineolmesartanf3)

A line graph showing the probability of achieving systolic blood pressure (SBP) below 130 mmHg at Week 8 with LOCF. The graph compares four groups: placebo, amlodipine 10 mg, amlodipine and olmesartan medoxomil 10/40 mg, and olmesartan 40 mg. The y-axis represents the percentage of patients with SBP <130 mmHg, and the x-axis displays the SBP measurements over time.*

FDA Label Image

Fig 4 (Amlodipineolmesartanf4)

A line graph depicting the probability of achieving diastolic blood pressure (DBP) less than 80 mmHg at Week 8 with LOCF. It compares different treatments including placebo, AML 10 mg, 0/40 mg, and amlodipine and olmesartan medoxomil 10/40 mg across baseline DBP values ranging from 95 to 110 mmHg.*

FDA Label Image

Fig 1 (Amlodipineolmesartanfigure1)

A line graph showing the probability of achieving systolic blood pressure (SBP) below 140 mmHg by Week 8. The x-axis represents baseline SBP (mmHg), and the y-axis shows the percentage of subjects with SBP <140 mmHg. Four groups are compared: placebo, amlodipine 10 mg, olmesartan 40 mg, and a combination of amlodipine and olmesartan medoxomil 10/40 mg.*

FDA Label Image

Strc 1 (Amlodipineolmesartanmedoxomilamlodipinestrc)

Chemical structure of amlodipine and olmesartan medoxomil active ingredients visible in the image, showing detailed molecular components and bonding.*

FDA Label Image

Strc 2 (Amlodipineolmesartanmedoxomilolmestrc)

Chemical structure diagram of Amlodipine and Olmesartan Medoxomil, showing the molecular arrangement of atoms and bonds characteristic of this dual active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.